Pediatric cancer chemotherapy: an updated review. I. Cis-Diammine--dichloroplatinum II (cisplatin), VM-26 (teniposide), VP-16 (etoposide), mitomycin C
- PMID: 394834
- DOI: 10.1016/s0305-7372(79)80067-5
Pediatric cancer chemotherapy: an updated review. I. Cis-Diammine--dichloroplatinum II (cisplatin), VM-26 (teniposide), VP-16 (etoposide), mitomycin C
Similar articles
-
VM 26 and VP 16-213: a comparative analysis.Cancer. 1977 Jul;40(1):334-42. doi: 10.1002/1097-0142(197707)40:1<334::aid-cncr2820400147>3.0.co;2-x. Cancer. 1977. PMID: 328129 Review.
-
Pharmacokinetics of intrapleural versus intravenous etoposide (VP 16) and teniposide (VM 26) in patients with malignant pleural effusion.Oncology. 1990;47(1):55-61. doi: 10.1159/000226785. Oncology. 1990. PMID: 2300386
-
Therapeutic trials with VP-16-213 and VM-26: active agents in small cell lung cancer, non-Hodgkin's lymphomas, and other malignancies.Cancer Treat Rep. 1979 Aug;63(8):1231-9. Cancer Treat Rep. 1979. PMID: 225026 Clinical Trial. No abstract available.
-
[Teniposide and cisplatin compared with etoposide and cisplatin for treatment of small cell lung cancer].Ai Zheng. 2002 Dec;21(12):1368-71. Ai Zheng. 2002. PMID: 12520751 Clinical Trial. Chinese.
-
Podophyllotoxin derivatives VP-16 and VM-26.Cancer Chemother Biol Response Modif. 1988;10:57-63. Cancer Chemother Biol Response Modif. 1988. PMID: 3079398 Review. No abstract available.
Cited by
-
G-quadruplexes as potential therapeutic targets for embryonal tumors.Molecules. 2013 Oct 10;18(10):12500-37. doi: 10.3390/molecules181012500. Molecules. 2013. PMID: 24152672 Free PMC article. Review.
-
VM26: phase I and II studies.Cancer Chemother Pharmacol. 1982;7(2-3):87-91. doi: 10.1007/BF00254527. Cancer Chemother Pharmacol. 1982. PMID: 7044595 Review. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources